Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Bradykinin | Bradykinin is an effective endothelium-dependent vasodilator that can lower blood pressure. Bradykinin can induce contraction of bronchial and intestinal non-vascular smooth muscle, increase vascular permeability, and participate in the mechanism of pain [1] [2] [3] [4] [5]. Uses: Scientific research. Group: Peptides. CAS No. 58-82-2. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-P0206. |  |
| Bradykinin | Bradykinin is a nonapeptide messenger produced from kallidin in the blood. Bradykinin has the selectivity for B2 over B1 receptors. It exhibits hypotensive and anti-inflammatory properties. Uses: Hypotensive agent. Synonyms: H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH; L-arginyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanyl-L-arginine; L-Bradykinin; Kallidin I; Callidin I; Kallidin 9. Grades: ≥95%. CAS No. 58-82-2. Molecular formula: C50H73N15O11. Mole weight: 1060.21. |  |
| Bradykinin 1-3 | Bradykinin 1-3, a 3-amino acid residue peptide fragment of Bradykinin, is an amino-truncated Bradykinin cleaved by Prolyl endopeptidase. Synonyms: Bradykinin (1-3); Arginyl-prolyl-proline; arginylprolylproline; L-Arginyl-L-prolyl-L-proline; H-RPP-OH. Grades: 95%. CAS No. 23815-91-0. Molecular formula: C16H28N6O4. Mole weight: 368.43. | |
| Bradykinin (1-5) | Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE). Uses: Scientific research. Group: Peptides. CAS No. 23815-89-6. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P1488. | |
| Bradykinin 1-5 | Bradykinin 1-5 is the main stable metabolite of Bradykinin and is formed by proteolysis of angiotensin-converting enzyme (ACE). Synonyms: H-RPPGF-OH; L-arginyl-L-prolyl-L-prolyl-glycyl-L-phenylalanine; Bradykinin (1-5); Bradykinin Fragment 1-5; 1-5-Bradykinin (9Cl); N-[2-({[1-(Arginylprolyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxyethylidene]phenylalanine. Grades: ≥95%. CAS No. 23815-89-6. Molecular formula: C27H40N8O6. Mole weight: 572.66. | |
| Bradykinin 1-6 | Bradykinin 1-6, a stable metabolite of Bradykinin, is an amino-truncated Bradykinin peptide cleaved by carboxypeptidase Y (CPY). Synonyms: H-Arg-Pro-Pro-Gly-Phe-Ser-OH; L-arginyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-serine; (S)-2-((S)-2-(2-((S)-1-((S)-1-((S)-2-amino-5-guanidinopentanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)-3-phenylpropanamido)-3-hydroxypropanoic acid; Bradykinin (1-6). Grades: 95%. CAS No. 23815-88-5. Molecular formula: C30H45N9O8. Mole weight: 659.73. | |
| Bradykinin (2-9) | Bradykinin (2-9) is an amino-truncated Bradykinin peptide. Bradykinin (2-9) is a metabolite of Bradykinin, cleaved by Aminopeptidase P. Uses: Scientific research. Group: Peptides. Alternative Names: Des-Arg1-bradykinin. CAS No. 16875-11-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P1490. | |
| Bradykinin 2-9 | Bradykinin 2-9, a metabolite of Bradykinin, is an amino-truncated Bradykinin peptide cleaved by Aminopeptidase P. Synonyms: Des-Arg1-bradykinin; H-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH; L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanyl-L-arginine; Bradykinin fragment 2-9; 2-9-Bradykinin. Grades: ≥95%. CAS No. 16875-11-9. Molecular formula: C44H61N11O10. Mole weight: 904.02. | |
| Bradykinin,5-(4-chloro-L-phenylalanine)-8-(4-chloro-L-phenylalanine)-(9ci) | Heterocyclic Organic Compound. Alternative Names: (P-CHLORO-PHE5,8)-BRADYKININ;[(PCL)PHE5,8] BRADYKININ;ARG-PRO-PRO-GLY-P-CHLORO-PHE-SER-PRO-P-CHLORO-PHE-ARG;ARG-PRO-PRO-GLY-P-CHLORO-PHE-SER-PRO-P-CHLORO-PHE-ARG-ACETATE;ARG-PRO-PRO-GLY-(PCL)PHE-SER-PRO-(PCL)PHE-ARG;BRADYKININ (P-CHLORO-PHE5,8);(H-PHE(4-. CAS No. 125229-63-2. Molecular formula: C50H71Cl2N15O11. Mole weight: 1129.1. Purity: 0.96. IUPACName: (2S) -2-[[ (2S) -2-[[ (2S) -1-[ (2S) -2-[[ (2S) -2-[[2-[[ (2S) -1-[ (2S) -1-[ (2S) -2-amino-5- (diaminomethylideneamino) pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3- (4-chlorophenyl) propanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbony. Canonical SMILES: C1CC (N (C1)C (=O)C2CCCN2C (=O)C (CCCN=C (N)N)N)C (=O)NCC (=O)NC (CC3=CC=C (C=C3)Cl)C (=O)NC (CO)C (=O)N4CCCC4C (=O)NC (CC5=CC=C (C=C5)Cl)C (=O)NC (CCCN=C (N)N)C (=O)O. Catalog: ACM125229632. |  |
| Bradykinin Fragment 1-7 | Bradykinin Fragment 1-7 is a seven-membered oligopeptide. Synonyms: Arg-Pro-Pro-Gly-Phe-Ser-Pro; Des-8,9-BK. Grades: ≥97% by HPLC. CAS No. 23815-87-4. Mole weight: 756.85. | |
| Bradykinin-GN_4 antimicrobial peptide precursor | Bradykinin-GN_4 antimicrobial peptide precursor is originally from Amolops granulosus. | |
| Bradykinin, H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH (RPPGFSPFR) | Induces the release of nitric oxide. Other physiological functions include stimulation of pain receptors, inhibition of cAMP accumulation, and induction of smooth muscle contraction and vasodilation. Also involved in edema resulting from trauma or injury. Improves post-ischemic recovery of heart via a nitric oxide-dependent mechanism. Group: Biochemicals. Grades: Highly Purified. CAS No. 58-82-2. Pack Sizes: 1mg, 5mg. Molecular Formula: C??H??N??O??. US Biological Life Sciences. |  Worldwide |
| Bradykinin-TR1 bradykinin-related peptide precursor | Bradykinin-TR1 bradykinin-related peptide precursor is originally from Amolops granulosus. | |
| (d-Arg0,hyp3,d-phe7)-bradykinin | Heterocyclic Organic Compound. Alternative Names: npc567;H-D-ARG-ARG-PRO-HYP-GLY-PHE-SER-D-PHE-PHE-ARG-OH;D-ARG-ARG-PRO-HYP-GLY-PHE-SER-D-PHE-PHE-ARG;D-ARG-ARG-PRO-HYDROXY-PRO-GLY-PHE-SER-D-PHE-PHE-ARG;D-ARG-[HYP3,D-PHE7]-BRADYKININ;(D-ARG0,HYP3,D-PHE7)-BRADYKININ;(D-Arg0,Hyp3,D-Phe7)bradikinin;D-Arg-L-. CAS No. 109333-26-8. Molecular formula: C60H87N19O13. Mole weight: 1282.45. Catalog: ACM109333268. | |
| (D-Arg0,Hyp3,Igl5,D-Igl7,Oic8)-Bradykinin | (D-Arg0,Hyp3,Igl5,D-Igl7,Oic8)-Bradykinin, a bradykinin antagonist, shows high affinity for both BK receptors. Uses: Bradykinin receptor antagonists. Synonyms: B9430; H-D-Arg-Arg-Pro-Hyp-Gly-Gly(indan-2-yl)-Ser-D-Gly(indan-2-yl)-Oic-Arg-OH; (N-(D-arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolyl-glycyl-2-indan-2-yl-L-glycyl-L-seryl-2-indan-2-yl-D-glycyl)-(2S,3aS,7aS)-octahydroindole-2-carbonyl)-L-arginine; H-D-Arg-Arg-Pro-Hyp-Gly-Igl-Ser-D-Igl-Oic-Arg-OH; L-Arginine, D-arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-(2S)-2-(2,3-dihydro-1H-inden-2-yl)glycyl-L-seryl-(2R)-2-(2,3-dihydro-1H-inden-2-yl)glycyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-. Grades: ≥95%. CAS No. 180981-09-3. Molecular formula: C64H95N19O13. Mole weight: 1338.56. | |
| [Des-Arg9]-Bradykinin | [Des-Arg9]-Bradykinin is a selective Bradykinin(B1) receptor agonist and increases intracellular Ca2+ in bronchoalveolar eosinophils from ovalbumin-sensitized and -challenged mice. Synonyms: H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-OH; L-arginyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanine; 9-De-arg-bradykinin; 9-Des-arg-BK; Des-arg(9)-bradykinin; 9-de-L-Argininebradykinin; 1-8-Bradykinin. Grades: ≥95%. CAS No. 15958-92-6. Molecular formula: C44H61N11O10. Mole weight: 904.02. | |
| [Des-Arg9]-Bradykinin acetate | [Des-Arg9]-Bradykinin acetate is a Bradykinin B 1 receptor agonist that displays selectivity for B 1 over B 2 receptors. Uses: Scientific research. Group: Peptides. CAS No. 23827-91-0. Pack Sizes: 5 mg; 10 mg; 25 mg. Product ID: HY-P0298A. | |
| [Des-Arg9]-Bradykinin TFA | [Des-Arg9]-Bradykinin TFA is a selective Bradykinin(B1) receptor agonist and increases intracellular Ca2+ in bronchoalveolar eosinophils from ovalbumin-sensitized and -challenged mice. Synonyms: 1-8-Bradykinin, mono(trifluoroacetate) (salt); H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-OH.TFA; L-arginyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanine trifluoroacetic acid. Grades: ≥95%. CAS No. 199433-70-0. Molecular formula: C44H61N11O10.C2HF3O2. Mole weight: 1018.05. | |
| Galanin (1-13)-Bradykinin (2-9) amide | Galanin (1-13)-Bradykinin (2-9) amide is a high affinity ligand and antagonist of galanin receptor. Synonyms: M35; Galanin Receptor Ligand M35; H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-NH2; glycyl-L-tryptophyl-L-threonyl-L-leucyl-L-asparagyl-L-seryl-L-alanyl-glycyl-L-tyrosyl-L-leucyl-L-leucyl-glycyl-L-prolyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanyl-L-argininamide; M35 Peptide. Grades: ≥95%. CAS No. 142846-71-7. Molecular formula: C107H153N27O26. Mole weight: 2233.52. | |
| Lys-Bradykinin | Lys-Bradykinin is an endogenous bradykinin receptor agonist with selectivity for the B2 receptor (Ki = 2.54 and 0.63 nM at human B1 and B2 receptors, respectively). It is used as a hypotensive agent that reduces peripheral vascular resistance in vivo. Uses: Hypotensive agent. Synonyms: Kallidin. CAS No. 342-10-9. Molecular formula: C56H85N17O12. Mole weight: 1188.39. | |
| Lys-Bradykinin acetate | Lys-Bradykinin acetate is an endogenous bradykinin receptor agonist with selectivity for the B2 receptor (Ki = 2.54 and 0.63 nM at human B1 and B2 receptors, respectively). It is used as a hypotensive agent that reduces peripheral vascular resistance in vivo. Synonyms: H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH.CH3CO2H; L-lysyl-L-arginyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanyl-L-arginine acetic acid. Grades: ≥95%. Molecular formula: C58H89N17O14. Mole weight: 1248.43. | |
| Lys-[Des-Arg9]Bradykinin | Lys-[Des-Arg9]Bradykinin is a potent and highly selective bradykinin B1 receptor agonist (Ki value 0.12 and > 30000 nM at human B1 and B2 receptors, respectively) with 16-fold potency against [Des-Arg9]-Bradykinin. It is used as a hypotensive agent and reduces peripheral vascular resistance in vivo. Uses: Hypotensive agent. Synonyms: des-Arg10-Kallidin; [Lys-des-Arg9]-Bradykinin. CAS No. 71800-36-7. Molecular formula: C50H73N13O11. Mole weight: 1032.21. | |
| Lys-[Des-Arg9]Bradykinin acetate | Lys-[Des-Arg9]Bradykinin acetate is a potent and highly selective bradykinin B1 receptor agonist (Kis are 0.12 and >30000 nM at human B1 and B2 receptors, respectively) with 16-fold potency against [Des-Arg9]-Bradykinin. It is used as a hypotensive agent and reduces peripheral vascular resistance in vivo. Synonyms: H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-OH.CH3CO2H; L-lysyl-L-arginyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanine acetic acid; 1-9-Kallidin acetate; N2-L-Lysyl-9-de-L-arginine-Bradykinin acetate. Grades: ≥95%. CAS No. 2760881-54-5. Molecular formula: C52H77N13O13. Mole weight: 1092.27. | |
| Lys-[Des-Arg9]Bradykinin TFA | Lys-[Des-Arg9]Bradykinin TFA, a naturally occurring kinin, is a potent and highly selective bradykinin B1 receptor agonist with a K i of 0.12 nM, 1.7 nM and 0.23 nM for human , mouse and rabbit B1 receptors , respectively. Lys-[Des-Arg9]Bradykinin TFA has low inhibitory activity on B2 receptors [1] [2]. Uses: Scientific research. Group: Peptides. CAS No. 2763588-90-3. Pack Sizes: 5 mg; 10 mg; 50 mg. Product ID: HY-103295A. | |
| Lys-lys-(hyp3,beta-(2-thienyl)-ala5,8,d-phe7)-bradykinin | Heterocyclic Organic Compound. Alternative Names: LYS-LYS-ARG-PRO-HYP-GLY-BETA-(2-THIENYL)-ALA-SER-D-PHE-BETA-(2-THIENYL)-ALA-ARG;LYS-LYS-ARG-PRO-HYP-GLY-BETA-(2-THIENYL)-ALA-SER-D-PHE-BETA-(2-THIENYL)-ALA-ARG-OH;LYS-LYS-ARG-PRO-HYP-GLY-THI-SER-D-PHE-THI-ARG;LYS-LYS-(HYP3,3-ALA(2-THIENYL)5,8,D-PHE7)-BRA. CAS No. 103412-40-4. Molecular formula: C62H95N19O14S2. Mole weight: 1394.67. Purity: 0.96. IUPACName: (2R) -3- [ (2S) -1- [ (2S) -2- [ [ (2S) -6-amino-2- [ [ (2S) -2, 6-diaminohexanoyl] amino] hexanoyl] amino] -5- (diaminomethylideneamino) pentanoyl] pyrrolidine-2-carbonyl] -2- [ [ (2S) -2-amino-3-thiophen-2-ylpropanoyl] - [ (2R) -2- [ [ (2S) -2- [ [ (2S) -2-amino-3-thiophen-2-ylpropanoyl] amino. Canonical SMILES: C1CC (N (C1)C (=O)C (CCCN=C (N)N)NC (=O)C (CCCCN)NC (=O)C (CCCCN)N)C (=O)N2CC (CC2C (=O)NCC (=O)NC (CC3=CC=CS3)C (=O)NC (CO)C (=O)NC (CC4=CC=CC=C4)C (=O)NC (CC5=CC=CS5)C (=O)NC (CCCN=C (N)N)C (=O)O)O. Density: 1.53g/cm³. Catalog: ACM103412404. | |
| [Phe8Y(CH-NH)Arg9]-Bradykinin | [Phe8Y(CH-NH)Arg9]-Bradykinin is a selective bradykinin B2 receptor agonist with 5-fold potency against bradykinin in vivo. It is resistant to carboxypeptidase cleavage. Uses: Hypotensive agent. Synonyms: Ppcna-BK; 8-Phe-9-psi-CH2NH-arg-bradykinin. CAS No. 118122-39-7. Molecular formula: C50H75N15O10. Mole weight: 1046.23. | |
| Retrobradykinin | Retrobradykinin, a bradykinin analog nonapeptide, shows no significant kinin activity. Synonyms: RFPSFGPPR. CAS No. 5991-13-9. Molecular formula: C50H73N15O11. Mole weight: 1060.22. | |
| Sar-[D-Phe8]-des-Arg9-Bradykinin | Sar-[D-Phe8]-des-Arg9-Bradykinin is a potent and selective bradykinin B1 receptor agonist (EC50 = 9.02 nM in rabbit aorta) that is resistant to aminopeptidase, kininase I and II (ACE) and neutral endopeptidase cleavage. It shows hypotensive and angiogenic activity in vivo. Uses: Hypotensive agent. Synonyms: Sar[DPhe8][des-Arg9]BK; [N-methylglycine,D-Phe8,des-Arg9]bradykinin. CAS No. 126959-88-4. Molecular formula: C47H66N12O11. Mole weight: 975.11. | |
| 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid Ethyl Ester | 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid Ethyl Ester is a useful synthetic intermediate. It is used to prepare quinapril derivatives as bradykinin B2 receptor antagonists. It is also used to synthesize quinolizidinone carboxylic acid selective M1 allosteric modulators. Group: Biochemicals. Grades: Highly Purified. CAS No. 41234-43-9. Pack Sizes: 250mg, 2.5g. Molecular Formula: C12H15NO2, Molecular Weight: 205.25. US Biological Life Sciences. | Worldwide |
| 1,3-Dichloro-2-methyl-benzene | 1,3-Dichloro-2-methyl-benzene is a useful synthetic intermediate. It can be used to prepare aryloxymethyl-substituted dibenzo[b,f]azocines as potential protein kinase A inhibitors. It can also be used to prepare dimethylglycine sulfonamides as potential bradykinin hB2 receptor antagonists. Isoconazole Impurity 10. Group: Biochemicals. Grades: Highly Purified. CAS No. 118-69-4. Pack Sizes: 10g, 25g. Molecular Formula: C7H6Cl2, Molecular Weight: 161.03. US Biological Life Sciences. | Worldwide |
| (1-6)-Icatibant | (1-6)-Icatibant is an impurity of Icatibant, which is a selective and specific antagonist of bradykinin B2 receptor. Synonyms: D-arginyl-L-arginyl-L-prolyl-L-hydroxyprolyl-glycyl-L-thienylalanine; D-Arg-Arg-Pro-Hyp-Gly-Thi-OH. CAS No. 2698340-93-9. Molecular formula: C31H50N12O8S. Mole weight: 750.88. | |
| 17-ODYA | 17-Octadecynoic acid is a suicide inhibitor of LTB4 ω-oxidase. 17-ODYA can completely inhibit the bradykinin-dependent transport of sodium chloride in rat TALH cells at a concentration of 10 μM. Synonyms: Alkynyl Stearic Acid;17-Octadecynoic acid. Grades: ≥98% by HPLC. CAS No. 34450-18-5. Molecular formula: C18H32O2. Mole weight: 280.45. | |
| 3-[4-[ (Methylamino) carbonyl]phenyl]-2-propenoic Acid | 3-[4-[ (Methylamino) carbonyl]phenyl]-2-propenoic Acid can be used as reactant/reagent in preparation of benzimidazoles and analogs as bradykinin antagonists. Group: Biochemicals. Grades: Highly Purified. CAS No. 160648-00-0. Pack Sizes: 50mg, 100mg. Molecular Formula: C11H11NO3, Molecular Weight: 205.21. US Biological Life Sciences. | Worldwide |
| 4-Cyano-L-β-homophenylglycine | 4-Cyano-L-β-homophenylglycine is used as a reactant in the preparation of novel diaminochroman carboxamides as potent nonpeptide antagonists of bradykinin B1 receptor. Synonyms: H-Phg(4-CN)-(C#CH2)OH; H-β-Phe(4-CN)-OH; (R)-3-Amino-3-(4-cyanophenyl)propanoic acid. Grades: ≥ 95%. CAS No. 738606-24-1. Molecular formula: C10H10N2O2. Mole weight: 190.2. | |
| (7-10)-Icatibant | (7-10)-Icatibant is an impurity of Icatibant, which is a selective and specific antagonist of bradykinin B2 receptor. Synonyms: L-seryl-D-1,2,3,4-tetrahydroisoquinolyl-3-Carbonyl-L-octahydroindole-2-carboxamido-L-arginine; H-Ser-D-Tic-Oic-Arg-OH; L-Arginine, L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2α,3aβ,7aβ)-octahydro-1H-indole-2-carbonyl-; ((2S,3aS,7aS)-1-((R)-2-(L-seryl)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)octahydro-1H-indole-2-carbonyl)-L-arginine. CAS No. 148416-85-7. Molecular formula: C28H41N7O6. Mole weight: 571.68. | |
| Acetaminophen-13C2,15N | Acetaminophen-13C2,15N is 13C and 15N labeled acetaminophen. Acetaminophen is a metabolite of phenacetin in the body. It reduces the synthesis and release of prostaglandins PGE1, bradykinin and histamine by inhibiting prostaglandin synthase in the hypothalamic thermoregulatory center. Group: Isotope-labeled synthetic intermediates. Alternative Names: Paracetamol-13C2,15N; 4-Acetamidophenol-13C2,15N; 4'-Hydroxyacetanilide-13C2,15N. CAS No. 360769-21-7. Molecular formula: C613C2H915NO2. Mole weight: 154.14. Canonical SMILES: [13CH3][13C]([15NH]C1=CC=C(C=C1)O)=O. Catalog: ACM360769217. | |
| Ac-Icatibant | Ac-Icatibant is an impurity of Icatibant, which is a selective and specific antagonist of bradykinin B2 receptor. Synonyms: Ac-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH; Acetyl-D-arginyl-L-arginyl-L-prolyl-L-hydroxyprolyl-glycyl-L-thienylalanyl-L-seryl-D-1,2,3,4-tetrahydroisoquinolyl-L-octahydroindole-L-arginine; L-Arginine, N2-acetyl-D-arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-. CAS No. 193618-65-4. Molecular formula: C61H91N19O14S. Mole weight: 1346.58. | |
| Anatibant hydrochloride | Anatibant (LF 16-0687; XY-2405) hydrochloride is a selective non-peptide bradykinin B2 receptor antagonist. Anatibant hydrochloride binds to the human, rat and guinea-pig recombinant B2 receptor with K i values of 0.67 nM, 1.74 nM and 1.37 nM, respectively. Anatibant hydrochloride crosses the blood-brain barrier (BBB). Anatibant hydrochloride can be used in research on brain damage diseases [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: LF 16-0687 hydrochloride; XY-2405 hydrochloride. CAS No. 209788-45-4. Pack Sizes: 1 mg. Product ID: HY-121156A. | |
| Angiotensin-converting enzyme | Angiotensin-converting enzyme (Kininase II) is a dicarboxypeptidase, it converts inactive Angiotensin I (Ang I) to active Ang II and degrades active bradykinin (BK). Angiotensin-converting enzyme is a potent vasoconstrictor, is often used in biochemical studies [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Kininase II; CD143. CAS No. 9015-82-1. Pack Sizes: 1 U. Product ID: HY-P2983. | |
| angiotensin-converting enzyme 2 | A transmembrane glycoprotein with an extracellular catalytic domain. Angiotensin-converting enzyme 2 functions as a carboxypeptidase, cleaving a single C-terminal residue from a distinct range of substrates. Catalytic efficiency is 400-fold higher with angiotensin II (1-8) as a substrate than with angiotensin I (1-10). Angiotensin-converting enzyme 2 also efficiently hydrolyses des-Arg9-bradykinin, but it does not hydrolyse bradykinin. In peptidase family M2. Group: Enzymes. Synonyms: ACE-2; ACE2; hACE2; angiotensin converting enzyme 2; angiotensin converting enzyme-2; Tmem27. Enzyme Commission Number: EC 3.4.17.23. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4076; angiotensin-converting enzyme 2; EC 3.4.17.23; ACE-2; ACE2; hACE2; angiotensin converting enzyme 2; angiotensin converting enzyme-2; Tmem27. Cat No: EXWM-4076. |  |
| Antagonist G | Antagonist G is a substance P analog, which is a broad spectrum neuropeptide growth factor antagonist and antiproliferative agent. It was developed for the treatment of small cell lung cancer. It could inhibit neuropeptide-dependent and -independent proliferation of small cell lung cancer in vitro. It also inhibits growth of SCLC xenografts in mice in vivo. It blocks Swiss 3T3 cell growth induced by vasopressin, gastrin-releasing peptide and bradykinin. It activates JNK and stimulates apoptosis. It is an anticancer agent and is resistant to degradation by peptidases. Synonyms: [Arg6,D-Trp7,9,N-MePhe8]-Substance P(6-11). Grades: 98%. CAS No. 115150-59-9. Molecular formula: C49H66N12O6S. Mole weight: 951.20. | |
| Avoralstat | Avoralstat, also known as BCX-4161, is an oral plasma kallikrein (PKK) inhibitor and Bradykinin inhibitor, used to treat hereditary angioedema. Synonyms: 3-[2-[(4-carbamimidoylphenyl)carbamoyl]-4-ethenyl-5-methoxyphenyl]-6-(cyclopropylmethylcarbamoyl)pyridine-2-carboxylic acid; BCX-4161; BCX 4161; BCX4161; Avoralstat. CAS No. 918407-35-9. Molecular formula: C28H27N5O5. Mole weight: 513.54. | |
| Berotralstat dihydrochloride | Berotralstat dihydrochloride is a low toxicity, effective, highly specific, second-generation, synthetic and orally active plasma kallikrein inhibitor used for the research of hereditary angioedema (HAE) attacks. Berotralstat dihydrochloride works by blocking the enzymatic activity of plasma kallikrein in releasing bradykinin, the major biologic peptide that promotes swelling and pain associated with attacks of HAE [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BCX7353 dihydrochloride. CAS No. 1809010-52-3. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-109127A. | |
| Bombinakinin-GAP | Bombinakinin-GAP is a bioactive bradykinin-related peptide that reduces 60% food intake following i.c.v. administration in rats. Synonyms: BOMBINAKININ-GAP; 573671-91-7; AKOS024457065; Bombinakinin M Gene Associated Peptide. CAS No. 573671-91-7. Molecular formula: C145H219N39O39S3. Mole weight: 3228.75. | |
| Bombinakinin M | Bombinakinin M is a potent bradykinin receptor agonist with selectivity for mammalian arterial smooth muscle bradykinin receptors, displaying ~ 50-fold greater potency than bradykinin. Synonyms: Maximakinin. CAS No. 509151-65-9. Molecular formula: C100H159N31O24. Mole weight: 2179.55. | |
| [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P is a broad spectrum neuropeptide inverse agonist and antagonist. It acts as a full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM) and antagonist at tachykinin, bradykinin, CCK and bombesin receptors. It induces apoptosis and inhibits cancer cell growth in vitro. Synonyms: 1-Arg-5-Phe-7,9-Trp-11-Leu-substance P; D-Arg(10)-D-Phe(5)-D-Trp(7,9)-Leu(11)-SP; substance P, phenylalanyl(5)-tryptophyl(7,9)-leucine(11)-. CAS No. 96736-12-8. Molecular formula: C79H109N19O12. Mole weight: 1516.85. | |
| [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate is a broad-spectrum neuropeptide inverse agonist and antagonist. It acts as a full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM) and antagonist at tachykinin, bradykinin, CCK, and bombesin receptors. It induces apoptosis and inhibits cancer cell growth in vitro. Synonyms: H-D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2.CH3CO2H; D-arginyl-L-prolyl-L-lysyl-L-prolyl-D-phenylalanyl-L-glutaminyl-D-tryptophyl-L-phenylalanyl-D-tryptophyl-L-leucyl-L-leucinamide acetic acid; [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-Substance P acetate. Grades: ≥95%. CAS No. 2918771-49-8. Molecular formula: C81H113N19O14. Mole weight: 1576.91. | |
| Des-D-Arg(1)-Icatibant | Des-D-Arg(1)-Icatibant is an impurity of Icatibant, which is a selective and specific antagonist of bradykinin B2 receptor. Synonyms: L-Arginyl-L-prolyl-L-hydroxyprolyl-glycyl-L-thienylalanyl-L-seryl-D-1,2,3,4-tetrahydroisoquinolyl-L-octahydroindole-L-arginine; Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH; Arg-Pro-Hyp-Gly-2Thi-Ser-D-Tic-Oic-Arg-OH; L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-L-arginine; Bradykinin, 3-(trans-4-hydroxy-L-proline)-5-[3-(2-thienyl)-L-alanine]-7-(D-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid)-8-[(2α,3aβ,7aβ)-L-octahydro-1H-indole-2-carboxylic acid]-. CAS No. 130334-60-0. Molecular formula: C53H77N15O12S. Mole weight: 1148.35. | |
| Des-L-Arg(2)-Icatibant | Des-L-Arg(2)-Icatibant is an impurity of Icatibant, which is a selective and specific antagonist of bradykinin B2 receptor. Synonyms: D-Arginyl-L-prolyl-L-hydroxyprolyl-glycyl-L-thienylalanyl-L-seryl-D-1,2,3,4-tetrahydroisoquinolyl-L-octahydroindole-L-arginine; D-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH; L-Arginine, D-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-. CAS No. 193740-38-4. Molecular formula: C53H77N15O12S. Mole weight: 1148.35. | |
| ELN 441958 | ELN441958 is a novel, potent and selective bradykinin B1 receptor antagonist with Ki value of 0.26 nM. It competitively inhibited the binding of the agonist [3H]DAKD to the human B1 receptor in IMR-90 lung fibroblast cell membranes. It is highly selective for B1 over B2 receptors and >500/ 2000-fold selective for the B1 over μ/δ-opioid receptor. It also inhibited human μ-, δ-, κ- opioid receptors and muscarinic M1 receptor with Ki values of 0.13, 0.69, 1.5 and 0.37 μM, respectively. It exhibited good permeability and metabolic stability in vitro. It exhibited high oral bioavailability and moderate plasma half-lives in rats and rhesus monkeys. It does not inhibit the activation of the human bradykinin B2 receptor at concentrations up to 10 μM. It has a moderate clearance and volume of distribution in both species following i.v. administration, consistent with the high metabolic stability in rat, rhesus, and human microsomes. Uses: Eln441958 exhibited high oral bioavailability and moderate plasma half-lives. Synonyms: ELN441958; ELN 441958; ELN-441958;7-Chloro-2-[3-[[9-(pyridin-4-yl)-3,9-diazaspiro[5.5]undecan-3-yl]carbonyl]phenyl]-2,3-dihydroisoindol-1-one. Grades: >98%. CAS No. 913064-47-8. Molecular formula: C29H29ClN4O2. Mole weight: 501.02. | |
| Fmoc-Oic-OH | Fmoc-Oic-OH is an amino acid derivative with an Fmoc protecting group, which can be used to synthesize bioactive peptide mimetics, such as [desArg 10 ]HOE 140, which has bradykinin B1 antagonist activity [1]. Uses: Scientific research. Group: Peptides. CAS No. 130309-37-4. Pack Sizes: 5 g; 10 g; 25 g; 50 g; 100 g. Product ID: HY-W041989. | |
| H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH·AcOH | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH·AcOH. Group: Biochemicals. Alternative Names: Bradykinin. Grades: Highly Purified. CAS No. 6846-3-3. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 250mg. US Biological Life Sciences. | Worldwide |
| H-Lys-arg-pro-ala-gly-phe-ser-pro-phe-arg-oh | Heterocyclic Organic Compound. Alternative Names: [LYS0, ALA3]-BRADYKININ; LYS-(ALA3)-BRADYKININ; LYS-ARG-PRO-ALA-GLY-PHE-SER-PRO-PHE-ARG; H-LYS-ARG-PRO-ALA-GLY-PHE-SER-PRO-PHE-ARG-OH. CAS No. 103545-18-2. Molecular formula: C54H83N17O12. Mole weight: 1162.34. Catalog: ACM103545182. | |
| H-Phe-arg-oh | Heterocyclic Organic Compound. Alternative Names: H-PHE-ARG-OH TFA;H-PHE-ARG-OH TRIFLUOROACETATE SALT; H-PHE-ARG-OH; phenylalanylarginine; Bradykinin(8-9); L-Phe-L-Arg-OH; Nα -(L-Phenylalanyl)-L-arginine; Phe-Arg-OH. CAS No. 1238-09-1. Molecular formula: C15H23N5O3. Mole weight: 435.4. Catalog: ACM1238091. | |
| Human Kininogen (Single Chain High Molecular Weight) | High Molecular Weight Kininogen (HK) is a non-enzymatic cofactor of the contact activation system. HK is thought to have two functions in the contact activation system. First, HK links Prekallikrein to a negatively charged surface thereby allowing activation of Kallikrein by surface bound Factor a-XIIa. HK also forms a complex with Factor XI and accelerates its activation to XIa by a-XIIa. Additionally HK serves as a source of Bradykinin, a potent vasoactive peptide important in hypotension studies. The protein purity is determined by SDS-PAGE. Group: Zymogens. Purity: >95% by SDS-PAGE. Kininogen. Mole weight: 120000. Storage: 2-8°C. Source: Human. Human Kininogen (Single Chain High Molecular Weight); Kininogen. Pack: 1mg. Cat No: CZY-028. | |
| Icatibant | Icatibant (HOE-140) is a potent and specific peptide antagonist of bradykinin B2 receptor with IC 50 and K i of 1.07 nM and 0.798 nM respectively [1] [2] [3]. Uses: Scientific research. Group: Peptides. Alternative Names: HOE 140. CAS No. 130308-48-4. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg. Product ID: HY-17446. | |
| Icatibant | Icatibant(HOE-140) is a selective and specific antagonist of bradykinin B2 receptor with IC50 and Ki of 1.07 nM and 0.798 nM respectively. Uses: Anti-inflammatory agents, non-steroidal. Synonyms: L-Arginine, D-arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-; H-D-Arg-Arg-Pro-Hyp-Gly-2Thi-Ser-D-Tic-Oic-Arg-OH; D-Arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-L-arginine; HOE140; HOE 140; HOE-140. Grades: >98%. CAS No. 130308-48-4. Molecular formula: C59H89N19O13S. Mole weight: 1304.52. | |
| Icatibant acetate | Icatibant acetate (HOE-140 acetate) is a potent and specific peptide antagonist of bradykinin B2 receptor with an IC 50 and K i of 1.07 nM and 0.798 nM respectively [1] [2] [3]. Uses: Scientific research. Group: Peptides. Alternative Names: HOE 140 acetate. CAS No. 138614-30-9. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-108896. | |
| Icatibant Acetate | Icatibant acetate is a selective antagonist of bradykinin B2 receptors. Icatibant is a medication approved for the treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency. Uses: Anti-inflammatory agents, non-steroidal. Synonyms: HOE 140 Acetate; HOE140 Acetate; HOE-140 Acetate; L-Arginine, D-arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-, acetate (1:x); H-D-Arg-Arg-Pro-Hyp-Gly-2Thi-Ser-D-Tic-Oic-Arg-OH.CH3CO2H; L-Arginine, D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2α,3aβ,7aβ)-octahydro-1H-indole-2-carbonyl-, acetate (salt); Firazyr. Grades: ≥95%. CAS No. 138614-30-9. Molecular formula: C59H89N19O13S.xC2H4O2. Mole weight: 1304.52 (free base). | |
| JA2 | JA2 is an inhibitor of metalloendopeptidase 24.15 that can potentiate the hypotensive response to bradykinin in rat [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 277333-45-6. Pack Sizes: 5 mg; 10 mg; 25 mg. Product ID: HY-164704. | |
| Kallidin(human,bovine)3acoh 4h2o | Heterocyclic Organic Compound. Alternative Names: LYSYL-BRADYKININ (HUMAN, BOVINE) 3ACOH 4H2O;LYS-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG (HUMAN, BOVINE) 3ACOH 4H2O;KALLIDIN (HUMAN, BOVINE) 3ACOH 4H2O. CAS No. 100900-38-7. Molecular formula: C62H105N17O22. Mole weight: 1440.6. Catalog: ACM100900387. | |
| Kallikrein-1 from Human, Recombinant | Kallikreins are serine protease enzymes having various physiological functions. Kallikreins are implicated in carcinogenesis and have potenital as novel cancer disease biomarkers. KLK1 is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. KLK1 is functionally conserved in its ability to release the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen. Human Kallikrein-1, also called as Kallidinogenase, Kininogenase or Kininogenin, is an active protein enzyme present in saliva, pancreatic juices, and urine that catalyzes the proteolysis of bradykininogen to bradykinin. Kallikrein-1, which derived from human or porcine, h...ysis by RP-HPLC. (b) Analysis by SDS-PAGE. Kallikrein. Mole weight: 28-32 kDa. Activity: 5 Units/mg. Stability: Lyophilized KLK1although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution KLK1 should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. Appearance: Sterile Filtered white lyophilized powder. Source: Pichia Pastoris. Species: Human. KLK1; KLK-1; HK1; HK-1; KLKR; KLK6; Tissue Kallikrein; Hklk1; EC 3.4.21.35; Kidney/pancreas/salivary gland kallikrein; Kallikrein-1. Cat No: NATE-0851. | |
| Kallikrein, Porcine pancreas | Kallikrein, Porcine pancreas (kininogenase) is capable of forming the kallikrenase kalinin system (KKS) in plasma and tissues, producing bradykinin and kalin peptides, respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: kininogenase; SK-827. CAS No. 9001-1-8. Pack Sizes: 100 mg; 250 mg. Product ID: HY-P2795. | |
| L-Arg(1)-Icatibant | L-Arg(1)-Icatibant is an impurity of Icatibant, which is a selective and specific antagonist of bradykinin B2 receptor. Synonyms: L-arginyl-L-arginyl-L-prolyl-L-hydroxyprolyl-glycyl-L-thienylalanyl-L-seryl-D-1,2,3,4-tetrahydroisoquinolyl-L-octahydroindole-L-arginine; Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH; L-Arginine, L-arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-. CAS No. 193618-59-6. Molecular formula: C59H89N19O13S. Mole weight: 1304.54. | |
| L-Arginine,d-arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-phenylalanyl-3-(2-thienyl)-L-alanyl- | Heterocyclic Organic Compound. Alternative Names: D-ARGINYL-[HYP3,THI5,8,D-PHE7]-BRADYKININ;D-ARGINYL-[HYP3,THI5,8,D-PHE7]-BRADYKININ 2ACOH 4H2O;D-ARG,[HYP3,THI5,8,D-PHE7]-BRADYKININ;(D-ARG0,HYP3,3-ALA(2-THIENYL)5,8,D-PHE7)-BRADYKININ;(D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ;[D-ARG0, HYP3. CAS No. 103412-42-6. Molecular formula: C56H83N19O13S2. Mole weight: 1294.51. Purity: 0.96. IUPACName: (2R) -3-[ (2S) -1-[ (2S) -2-[[ (2R) -2-amino-5- (diaminomethylideneamino) pentanoyl]amino]-5- (diaminomethylideneamino) pentanoyl]pyrrolidine-2-carbonyl]-2-[[ (2S) -2-amino-3-thiophen-2-ylpropanoyl]-[ (2R) -2-[[ (2S) -2-[[ (2S) -2-amino-3-thiophen-2-ylpropanoyl]amino]-3-hyd. Canonical SMILES: C1CC (N (C1)C (=O)C (CCCN=C (N)N)NC (=O)C (CCCN=C (N)N)N)C (=O)N2CC (CC2C (=O)NCC (=O)NC (CC3=CC=CS3)C (=O)NC (CO)C (=O)NC (CC4=CC=CC=C4)C (=O)NC (CC5=CC=CS5)C (=O)NC (CCCN=C (N)N)C (=O)O)O. Density: 1.58g/cm³. Catalog: ACM103412426. | |
| lysine carboxypeptidase | A zinc enzyme found in plasma. Inactivates bradykinin and anaphylatoxins in blood plasma. In peptidase family M14 (carboxypeptidase A family). Group: Enzymes. Synonyms: carboxypeptidase N; arginine carboxypeptidase; kininase I; anaphylatoxin inactivator; plasma carboxypeptidase B; creatine kinase conversion factor; bradykinase; kininase Ia; hippuryllysine hydrolase; bradykinin-decomposing enzyme; protaminase; CPase N; creatinine kinase convertase; peptidyl-L-lysine(-L-arginine) hydrolase; CPN. Enzyme Commission Number: EC 3.4.17.3. CAS No. 9013-89-2. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4077; lysine carboxypeptidase; EC 3.4.17.3; 9013-89-2; carboxypeptidase N; arginine carboxypeptidase; kininase I; anaphylatoxin inactivator; plasma carboxypeptidase B; creatine kinase conversion factor; bradykinase; kininase Ia; hippuryllysine hydrolase; bradykinin-decomposing enzyme; protaminase; CPase N; creatinine kinase convertase; peptidyl-L-lysine(-L-arginine) hydrolase; CPN. Cat No: EXWM-4077. | |
| M617 | M617 is a chimeric peptide that acts as a selective galanin GAL1 receptor agonist with Ki values of 0.23 and 5.71 nM for GAL1 and GAL2 receptors respectively. It enhances food consumption in rats following i.c.v. administration and reduces CAP-induced inflammatory pain. Synonyms: M617; M 617; M-617; Galanin(1-13)-Gln14-bradykinin(2-9)amide. CAS No. 860790-38-1. Molecular formula: C112H161N29O28. Mole weight: 2361.68. | |
| MEN 11270 | MEN 11270 is a B2 bradykinin receptor antagonist. It can block hypotension and bronchoconstriction in vivo. Uses: Bradykinin receptor antagonists. Synonyms: MEN 11270; MEN11270; MEN-11270. Grades: ≥95% by HPLC. CAS No. 235082-52-7. Molecular formula: C60H90N20O11S. Mole weight: 1299.56. | |
| MK0686 | MK0686 is a bradykinin B1 receptor antagonist. It exhibits suitable pharmacokinetic properties and efficient ex vivo receptor occupancy for further development as a novel approach for the treatment of pain and inflammation. It had been in phase II clinical trials by Merck Sharp & Dohme for the treatment of postherpetic neuralgia, postoperative pain and osteoarthritis. But it is discontinued now. Uses: Mk0686 is used for the treatment of postherpetic neuralgia, postoperative pain and osteoarthritis. Synonyms: MK0686; MK 0686; MK-0686;Methyl 2-chloro-6- [3-fluoro-4- [ (1R) -1- [ [1- [ (2, 2, 2-trifluoroacetyl) amino] cyclopropanecarbonyl] amino] ethyl] phenyl] benzoate; Methyl (R)-3-chloro-3'-fluoro-4'-(1-(1-(2,2,2-trifluoroacetamido)cyclopropane-1-carboxamido)ethyl)-[1,1'-biphenyl]-2-carboxyla. Grades: 98%. CAS No. 578727-68-1. Molecular formula: C22H19ClF4N2O4. Mole weight: 486.85. | |
| Native Human Kallikrein | Plasma kallikrein is an enzyme. This enzyme catalyses the following chemical reaction:Selective cleavage of some Arg-and Lys-bonds, including Lys-Arg and Arg-Ser in (human) kininogen to release bradykinin. This enzyme is formed from plasma prokallikrein (Fletcher factor) by factor XIIa. Group: Enzymes. Synonyms: serum kallikrein; kininogenin; kallikrein I; kallikrein II; kininogenase; kallikrein; callicrein; glumorin; padreatin; padutin; kallidinogenase; bradykininogenase; panceatic kallikrein; onokrein P; dilminal D; depot-Padutin; urokallikrein; urinary kallikrein; 9001-01-8; EC 3.4.21.34; plasma kallikrein. Enzyme Commission Number: EC 3.4.21.34. CAS No. 9001-1-8. Kallikrein. Activity: Type I, > 5 units/mg protein; Type II, 1-5 units/mg protein. Storage: -20°C. Form: Type I, buffered aqueous solution, Solution in 20 mM Tris-HCl, pH 7.8 with 100 mM NaCl; Type II, lyophilized powder. Source: Human plasma. Species: Human. serum kallikrein; kininogenin; kallikrein I; kallikrein II; kininogenase; kallikrein; callicrein; glumorin; padreatin; padutin; kallidinogenase; bradykininogenase; panceatic kallikrein; onokrein P; dilminal D; depot-Padutin; urokallikrein; urinary kallikrein; 9001-01-8; EC 3.4.21.34; plasma kallikrein. Cat No: NATE-0361. | |
Our database is helping our users find suppliers everyday.
